Related Experiment Videos

The heart and pericardial effusions in CDGS-I (carbohydrate-deficient glycoprotein syndrome type I)

B Kristiansson1, H Stibler, N Conradi

  • 1Department of Pediatrics, Göteborg University, Sweden.

Insights

Children with carbohydrate-deficient glycoprotein syndrome type I (CDGS-I) often develop pericardial effusions. Abnormal glycoprotein levels in blood and pericardial fluid suggest a damaged pericardial protein barrier contributes to this condition.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Pathology

Background:

  • Carbohydrate-deficient glycoprotein syndrome type I (CDGS-I) is a rare genetic disorder.
  • Pericardial effusion, fluid accumulation around the heart, can occur in CDGS-I patients.

Purpose of the Study:

  • To investigate the biochemical basis of pericardial effusions in CDGS-I.
  • To explore the role of glycoproteins in the pathogenesis of pericardial effusion in CDGS-I.

Main Methods:

  • Analysis of glycoprotein concentrations and isoforms in blood and pericardial fluid.
  • Correlation analysis between protein concentration ratios, molecular mass, and sialic acid content.
  • Histopathological examination of pericardial tissue.

Main Results:

  • Pericardial effusions were observed in 60% of CDGS-I patients, with 30% requiring pericardectomy.
  • Lower blood concentrations of glycoproteins and albumin were noted.
  • Similar abnormal glycoprotein isoforms were present in both blood and pericardial fluid.
  • A negative correlation between protein concentration ratio (pericardial fluid/blood) and molecular mass was found in CDGS-I patients.

Conclusions:

  • A compromised pericardial protein barrier is implicated in the development of pericardial effusion in CDGS-I.
  • Glycoprotein abnormalities contribute to fluid accumulation in the pericardium.
  • Further research into the pericardial protein barrier in CDGS-I is warranted.

Related Concept Videos